Sofosbuvir/daclatasvir combination could be produced for $200 per hepatitis C cure

Month-by-month tracking of the prices paid in India for the chemicals used to make hepatitis C direct-acting antivirals shows that it is now possible to make and sell a combination of drugs to cure hepatitis C for less than $200, Dr Andrew Hill of Liverpool University told the Second European HIV Hepatitis Co-infection Conference in London last week.If those drugs were bought at list price in the United States they would cost approximately $147,000 for a 1